Last Updated: June 18, 2026

Patent: 7,762,994

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,762,994

Title:	Needle mounting system and a method for mounting a needle assembly
Abstract:	A needle mounting system and methods for mounting a needle assembly on a needle mount are disclosed. The needle mounting system includes a needle hub having protrusions extending radially inward. A needle mount has a plurality of slots to receive the protrusions. The slots have a first portion that defines a passageway substantially parallel to a longitudinal axis of the needle mount and a second portion substantially perpendicular to the axis. The needle hub and mount provide a method wherein a needle assembly may be mounted on an injection device without completely rotating the needle hub relative to the needle mount.
Inventor(s):	Henrik Sonderskov Klint, Jim Radmer, Jorgen K Smedegaard, Jan Frank Nielsen, Peter Moller Jensen, Jens Moller Jensen
Assignee:	Novo Nordisk AS
Application Number:	US11/778,274
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,762,994
Patent Claims:	see list of patent claims

Details for Patent 7,762,994

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	NOVOLOG MIX 70/30	insulin aspart protamine and insulin aspart	Injectable Suspension	021172	November 01, 2001	⤷ Start Trial	2027-07-16
Novo Nordisk Inc.	NOVOLOG MIX 70/30	insulin aspart protamine and insulin aspart	Injectable Suspension	021172	May 03, 2002	⤷ Start Trial	2027-07-16
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	June 16, 2005	⤷ Start Trial	2027-07-16
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	October 31, 2013	⤷ Start Trial	2027-07-16
Novo Nordisk Inc.	NOVOLOG MIX 50/50	insulin aspart protamine and insulin aspart	Injectable Suspension	021810	August 26, 2008	⤷ Start Trial	2027-07-16
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	September 25, 2015	⤷ Start Trial	2027-07-16
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 7,762,994

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Austria	E344076	⤷ Start Trial
Austria	E439883	⤷ Start Trial
Australia	2003243922	⤷ Start Trial
Canada	2491356	⤷ Start Trial
China	100502968	⤷ Start Trial
China	1665558	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.